SCHEMBL12639928

SCHEMBL12639928

O=c1c(O)c(-c2c(O)c(O)c(O)c(O)c2O)oc2cc(O)cc(O)c12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 5/20 0.70
▸ MEN1 O00255 9/20 0.69
▸ KMT2A Q03164 9/20 0.69
▸ CYP1A2 P05177 8/20 0.69
▸ CYP1A1 P04798 7/20 0.69
▸ CYP1B1 Q16678 7/20 0.69
▸ CYP3A4 P08684 6/20 0.69
▸ CYP2C9 P11712 6/20 0.69
▸ FTO Q9C0B1 6/20 0.69
▸ XDH P47989 6/20 0.69
▸ MAPT P10636 5/20 0.69
▸ KDM4E B2RXH2 5/20 0.69
▸ ALOX15 P16050 5/20 0.69
▸ HSD17B10 Q99714 5/20 0.69
▸ ALDH1A1 P00352 4/20 0.69
▸ HPGD P15428 4/20 0.69
▸ CSNK2A2 P19784 4/20 0.69
▸ DAPK1 P53355 4/20 0.69
▸ BACE1 P56817 4/20 0.69
▸ CSNK2B P67870 4/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22738241 0.90 MEN1 (0.78) APPMEN1KMT2ACYP1A2CYP1A1
SCHEMBL12639989 0.86 MEN1 (0.68) APPMEN1KMT2ACYP1A2CYP1A1
SCHEMBL8816390 0.86 APP (0.74) APPMEN1KMT2ACYP1A2CYP1A1
SCHEMBL12639930 0.84 APP (0.71) APPMEN1KMT2ACYP1A2CYP1A1
SCHEMBL10716775 0.83 MEN1 (0.79) APPMEN1KMT2ACYP1A2CYP1A1
SCHEMBL28432225 0.83 MEN1 (0.85) APPMEN1KMT2ACYP1A2CYP1A1
Datiscetin SCHEMBL30822630 0.83 APP (1.00) APPMEN1KMT2ACYP1A2CYP1A1
Datiscetin SCHEMBL43916 0.83 APP (1.00) APPMEN1KMT2ACYP1A2CYP1A1
Datiscetin SCHEMBL29737517 0.83 APP (1.00) APPMEN1KMT2ACYP1A2CYP1A1
Myricetin SCHEMBL3503992 0.82 MEN1 (1.00) APPMEN1KMT2ACYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7935714-B2 Compositions for sleeping disorders Bright Future Pharmaceutical Laboratories (HK) 2011-05-03 — — US disclosed
US-7935714-B2 Compositions for sleeping disorders Bright Future Pharmaceutical Laboratories (HK) 2011-05-03 — — US disclosed
US-20090124627-A1 COMPOSITIONS FOR SLEEPING DISORDERS CHAN HSIAO CHANG 2009-05-14 — — US disclosed
US-20090124627-A1 COMPOSITIONS FOR SLEEPING DISORDERS CHAN HSIAO CHANG 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124627-A1 COMPOSITIONS FOR SLEEPING DISORDERS PER2, CRY1, CRY2 APP 661/4885MEN1 4015/4885KMT2A 353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback